Spastic Paraparesis
Symptoms, Doctors, Treatments, Advances & More

Spastic Paraparesis Overview

Save information for later
Sign Up

Learn About Spastic Paraparesis

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Spastic Paraparesis Local Doctors?
Elite in Spastic Paraparesis
Elite in Spastic Paraparesis

St. Marianna University School Of Medicine

Kawasaki, JP 

Yoshihisa Yamano practices in Kawasaki, Japan. Yamano is rated as an Elite expert by MediFind in the treatment of Spastic Paraparesis. Their top areas of expertise are HTLV-1 Associated Myelopathy, Spastic Paraparesis, Relapsing Polychondritis, Thrombectomy, and Thalamotomy.

Elite in Spastic Paraparesis
Elite in Spastic Paraparesis
Kagoshima, JP 

Satoshi Nozuma practices in Kagoshima, Japan. Mr. Nozuma is rated as an Elite expert by MediFind in the treatment of Spastic Paraparesis. His top areas of expertise are HTLV-1 Associated Myelopathy, Spastic Paraparesis, Myelitis, and Spasticity.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Spastic Paraparesis
Elite in Spastic Paraparesis

Office

1520 San Pablo St Ste 3000, 
Los Angeles, CA 
Languages Spoken:
English
Offers Telehealth

John Ringman is a Neurologist in Los Angeles, California. Dr. Ringman is rated as an Elite provider by MediFind in the treatment of Spastic Paraparesis. His top areas of expertise are Alzheimer's Disease, Dementia, Spastic Paraparesis, and Lewy Body Dementia (LBD).

What are the latest Spastic Paraparesis Clinical Trials?
Immuno-Virological Evaluation of Human T Cell Leukemia Virus Type-1 Associated Myelopathy (HAM/TSP)

Objective: Human T-lymphotropic virus type-I-associated myelopathy / tropical spastic paraparesis (HAM/TSP) is a rare neurologic disorder that affects less than 5% of patients infected with the HTLV-I virus. The purpose of this protocol is to study the natural history of HAM/TSP by monitoring clinical progression of patients longitudinally. Additionally, we will attempt to define the virological and immunolo...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Phase I/II Study of Teriflunomide in HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis

Background: HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a rare, progressive disease. It occurs in some people infected with the HTLV-1 virus. It leads to weakness in the lower limbs and other serious problems. It has no treatment. Teriflunomide is a drug used to treat multiple sclerosis. It reduces immune cells that make the disease worse. Researchers want to learn if this drug can ...